LMR Partners’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 828 |
|
|
2024
Q3 | – | Sell |
-33,900
| Closed | -$1.3M | – | 629 |
|
|
2024
Q2 | $1.3M | Buy |
+33,900
| New | +$1.3M | 0.01% | 296 |
|
|
2024
Q1 | – | Sell |
-114,069
| Closed | -$6.83M | – | 739 |
|
|
2023
Q4 | $6.83M | Buy |
114,069
+56,940
| +100% | +$3.41M | 0.08% | 151 |
|
|
2023
Q3 | $2.17M | Buy |
57,129
+38,693
| +210% | +$1.47M | 0.02% | 242 |
|
|
2023
Q2 | $1.68M | Buy |
+18,436
| New | +$1.68M | 0.02% | 270 |
|
|
2022
Q2 | – | Sell |
-14,219
| Closed | -$722K | – | 1278 |
|
|
2022
Q1 | $722K | Buy |
+14,219
| New | +$722K | 0.01% | 913 |
|
|
2021
Q4 | – | Sell |
-121,111
| Closed | -$3.99M | – | 1138 |
|
|
2021
Q3 | $3.99M | Buy |
+121,111
| New | +$3.99M | 0.05% | 295 |
|